Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

CUSIP: 05337M104

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Shares outstanding
98,762,388
Total 13F shares
7,025,014
Share change
-60,693,049
Total reported value
$98,771,327
Price per share
$14.06
Number of holders
10
Value change
-$1,024,949,936
Number of buys
3
Number of sells
110

Quarterly Holders Quick Answers

What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q2 2024

As of 30 Jun 2024, Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,025,014 shares. The largest 10 holders included Vivo Capital, LLC, Tri Locum Partners LP, MPM BIOIMPACT LLC, Knoll Capital Management, LLC, Knott David M Jr, SCHULHOFF & CO INC, Ameritas Investment Partners, Inc., 1620 INVESTMENT ADVISORS, INC., CWM, LLC, and HUNTINGTON NATIONAL BANK. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.